Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Omeros Corp (OMER)

Omeros Corp (OMER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Omeros: Q2 Earnings Snapshot AP - Wed Aug 7, 4:16PM CDT

Omeros: Q2 Earnings Snapshot

OMER : 3.93 (-1.75%)
Omeros: Q1 Earnings Snapshot AP - Wed May 15, 3:11PM CDT

Omeros: Q1 Earnings Snapshot

OMER : 3.93 (-1.75%)
Omeros: Q4 Earnings Snapshot AP - Mon Apr 1, 3:17PM CDT

Omeros: Q4 Earnings Snapshot

OMER : 3.93 (-1.75%)
Omeros: Q3 Earnings Snapshot AP - Thu Nov 9, 2023

Omeros: Q3 Earnings Snapshot

OMER : 3.93 (-1.75%)
Omeros: Q2 Earnings Snapshot AP - Wed Aug 9, 2023

Omeros: Q2 Earnings Snapshot

OMER : 3.93 (-1.75%)
Why Shares of Omeros Dropped on Monday Motley Fool - Mon Jun 12, 2023

The clinical-stage biopharmaceutical released trials data through a presentation.

OMER : 3.93 (-1.75%)
Omeros: Q1 Earnings Snapshot AP - Tue May 9, 2023

Omeros: Q1 Earnings Snapshot

OMER : 3.93 (-1.75%)
Omeros Corporation to Announce First Quarter Financial Results on May 9, 2023 Business Wire - Thu May 4, 2023

Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its first quarter financial results for the period ended March 31, 2023, on Tuesday, May 9, 2023, after the market closes....

OMER : 3.93 (-1.75%)
Omeros Corporation Reports Interim Data with Alternative Pathway Inhibitor OMS906 as Monotherapy in Patients with Paroxysmal Nocturnal Hemoglobinuria Business Wire - Tue Apr 25, 2023

Omeros Corporation (Nasdaq: OMER) today announced positive results from a pre-specified interim analysis of its ongoing Phase 1b clinical trial of OMS906, the company’s lead MASP-3 inhibitor, in complement-inhibitor-naïve...

OMER : 3.93 (-1.75%)
North America Could Possibly Emerge as the Market Leader for Billion Dollar Detox Drinks Industry FinancialNewsMedia - Tue Apr 18, 2023

EQNX::TICKER_START (NASDAQ:CELH),(NASDAQ:OMER),(NYSE:MRK),(NASDAQ:RXDX) EQNX::TICKER_END

CELH : 34.28 (-1.49%)
RXDX : 199.92 (+0.09%)
HUGE : 5.8435 (-10.10%)
OMER : 3.93 (-1.75%)
MRK : 118.64 (+0.30%)

Barchart Exclusives

GeneDx - AI Healthcare Leader Barchart - 5 minutes ago
Summary GeneDx Holdings Corp. offers AI-driven genomics-related diagnostic services, focusing on pediatrics, rare diseases, and hereditary cancer screening, with significant recent price appreciation. Barchart's technical indicators show 100% buy signals, a 919.55% gain in the last year, and strong momentum above key moving averages. Fundamental factors include a $970 million... Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot